Chemical Industry Setting a New Survival Benchmark: Evaluating Sacituzumab Tirumotecan (Sac-TMT) in Recurrent Endometrial Cancer Main Facts: A Breakthrough in Gynecological Oncology The landscape of recurrent endometrial cancer treatment is… Lina HopeOctober 27, 2026
